Does BIMEKIZUMAB-BKZX Cause Product availability issue? 364 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 364 reports of Product availability issue have been filed in association with BIMEKIZUMAB-BKZX. This represents 6.8% of all adverse event reports for BIMEKIZUMAB-BKZX.
364
Reports of Product availability issue with BIMEKIZUMAB-BKZX
6.8%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
17
Hospitalizations
How Dangerous Is Product availability issue From BIMEKIZUMAB-BKZX?
Of the 364 reports, 17 (4.7%) required hospitalization.
Is Product availability issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 364 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Psoriasis (621)
Drug ineffective (402)
Off label use (335)
Psoriatic arthropathy (301)
Injection site pain (263)
Therapy interrupted (252)
Hidradenitis (233)
Inappropriate schedule of product administration (214)
Incorrect dose administered (209)
What Other Drugs Cause Product availability issue?
RUXOLITINIB (2,142)
LISDEXAMFETAMINE DIMESYLATE (1,530)
CERTOLIZUMAB PEGOL (1,381)
VEDOLIZUMAB (636)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610)
METHYLPHENIDATE (444)
SECUKINUMAB (399)
LACOSAMIDE (359)
BRIVARACETAM (324)
SACUBITRIL\VALSARTAN (283)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Product availability issue Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES